Organicell Regenerative Medicine, Inc.
Organicell Regenerative Medicine, Inc. (OCEL) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · OCEL · as of Sep 30, 2023
Ownership Breakdown
1
Institutional Holders
$300
Total Inst. Value
7.28M
Shares Outstanding
freeFloat 9796.20%
30,000
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
OCEL largest shareholders · institutional ownership
Q3 2023 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
MATHES COMPANY, INC. biological products, (no diagnostic substances) | 30.0K | 0.21% | 0.21% | $1.00M | Oct 26, 2023 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2023 vs prior quarter
Q3 2023
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
OCEL insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Leider Harry L. Chief Executive Officer | Jun 29, 2023 | Purchase | 500,000 | $0.01 | $5.0K | 1.05M | Form 4 ↗ |
Leider Harry L. Chief Executive Officer | Jun 28, 2023 | Purchase | 549,450 | $0.01 | $5.4K | 549.5K | Form 4 ↗ |
Leider Harry L. Chief Executive Officer | Dec 19, 2023 | Sale | 5,248 | $1.31 | $6.9K | 0 | Form 4 ↗ |
Skycrest Holdings, LLC 10 percent owner | Jul 7, 2023 | Purchase | 320,710 | $0.01 | $2.9K | 51.72M | Form 4 ↗ |
Skycrest Holdings, LLC 10 percent owner | Jun 29, 2023 | Purchase | 200,000 | $0.01 | $1.8K | 51.40M | Form 4 ↗ |
Skycrest Holdings, LLC 10 percent owner | Jun 28, 2023 | Purchase | 400,000 | $0.01 | $3.6K | 51.20M | Form 4 ↗ |
Leider Harry L. Chief Executive Officer | Jun 28, 2023 | Purchase | 549,450 | $0.10 | $54.4K | 549.5K | Form 4 ↗ |
Skycrest Holdings, LLC 10 percent owner | Jun 26, 2023 | Purchase | 800,000 | $0.01 | $7.2K | 50.80M | Form 4 ↗ |
Sinnreich Matthew Phillip President and Acting CEO | Oct 31, 2022 | J-Other | 6,976,000 | — | — | 0 | Form 4 ↗ |
Sinnreich Matthew Phillip President and Acting CEO | Oct 31, 2022 | J-Other | 6,979 | — | — | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Organicell Regenerative Medicine, Inc. (OCEL) is primarily owned by institutional investors, who hold approximately 0.4% of total shares outstanding. Company insiders own approximately 0.00%, while retail and public investors account for the remaining 9795.79%.
The largest institutional shareholder of Organicell Regenerative Medicine, Inc. is MATHES COMPANY, INC., holding approximately 30,000 shares — equal to 0.21% of outstanding shares — as of September 30, 2023.
A total of 1 institutional investors currently hold OCEL stock, with a combined institutional value of approximately $300 as of the most recent 13F filing period.
Frequently asked questions
OCEL ownershipOrganicell Regenerative Medicine, Inc. (OCEL) is primarily owned by institutional investors, who hold approximately 0.4% of shares. The largest shareholder is MATHES COMPANY, INC. with a 0.21% stake. Company insiders hold 0.00%. Data sourced from SEC Form 13F as of September 30, 2023.